These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. In Barrett's epithelial cells, weakly acidic bile salt solutions cause oxidative DNA damage with response and repair mediated by p38. Huo X; Dunbar KB; Zhang X; Zhang Q; Spechler SJ; Souza RF Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G464-G478. PubMed ID: 31984785 [TBL] [Abstract][Full Text] [Related]
10. Toll-like Receptor 2 Signalling and the Lysosomal Machinery in Barrett's Esophagus. Verbeek RE; Siersema PD; Vleggaar FP; Ten Kate FJ; Posthuma G; Souza RF; de Haan J; van Baal JW J Gastrointestin Liver Dis; 2016 Sep; 25(3):273-82. PubMed ID: 27689189 [TBL] [Abstract][Full Text] [Related]
11. Malignant transformation of non-neoplastic Barrett's epithelial cells through well-defined genetic manipulations. Zhang X; Yu C; Wilson K; Zhang HY; Melton SD; Huo X; Wang DH; Genta RM; Spechler SJ; Souza RF PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927195 [TBL] [Abstract][Full Text] [Related]
12. Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia. Inge LJ; Fowler AJ; Paquette KM; Richer AL; Tran N; Bremner RM J Thorac Cardiovasc Surg; 2013 Feb; 145(2):531-8. PubMed ID: 23142123 [TBL] [Abstract][Full Text] [Related]
13. Immature myeloid progenitors promote disease progression in a mouse model of Barrett's-like metaplasia. Kong J; Sai H; Crissey MA; Jhala N; Falk GW; Ginsberg GG; Abrams JA; Nakagawa H; Wang K; Rustgi AK; Wang TC; Lynch JP Oncotarget; 2015 Oct; 6(32):32980-3005. PubMed ID: 26460825 [TBL] [Abstract][Full Text] [Related]